Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,765 | -9,607 | -4,372 | -26,353 | -19,919 |
| Depreciation Amortization | 603 | 422 | 171 | 692 | 530 |
| Income taxes - deferred | -1,803 | -1,803 | -1,803 | N/A | N/A |
| Accounts receivable | -141 | -147 | 95 | 50,314 | 50,206 |
| Other Working Capital | -9,577 | -9,438 | -6,336 | 18,704 | 21,559 |
| Other Operating Activity | 5,136 | 3,063 | 1,003 | -42,298 | -43,014 |
| Operating Cash Flow | $-22,547 | $-17,510 | $-11,242 | $1,059 | $9,362 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 196 | N/A | N/A | N/A | N/A |
| PPE Investments | -583 | -444 | -188 | -413 | -429 |
| Purchase Of Investment | -16,403 | -12,635 | -7,718 | -53,412 | -40,628 |
| Sale Of Investment | 53,497 | 47,664 | 23,332 | 7,666 | N/A |
| Investing Cash Flow | $36,707 | $34,585 | $15,426 | $-46,159 | $-41,057 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -41 | -29 | -13 | -32 | -23 |
| Common Stock Issued | 6,713 | 5,869 | 51 | 1,787 | 1,645 |
| Common Stock Repurchased | -37 | -37 | -37 | -17 | -17 |
| Other Financing Activity | -199 | -174 | 0 | -106 | -95 |
| Financing Cash Flow | $6,436 | $5,629 | $1 | $1,632 | $1,510 |
| Exchange Rate Effect | -532 | -192 | -100 | -873 | -795 |
| Beginning Cash Position | 11,936 | 11,936 | 11,936 | 56,277 | 56,277 |
| End Cash Position | 32,000 | 34,448 | 16,021 | 11,936 | 25,297 |
| Net Cash Flow | $20,064 | $22,512 | $4,085 | $-44,341 | $-30,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,547 | -17,510 | -11,242 | 1,059 | 9,362 |
| Capital Expenditure | -583 | -444 | -188 | -413 | -429 |
| Free Cash Flow | -23,130 | -17,954 | -11,430 | 646 | 8,933 |